Cargando…
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
The low immunogenicity, insufficient infiltration of T lymphocytes, and dismal response to immune checkpoint blockade therapy pose major difficulties in immunotherapy of pancreatic cancer. Photoimmunotherapy by photodynamic therapy (PDT) can induce an antitumor immune response by triggering immunoge...
Autores principales: | Sun, Fang, Zhu, Qiurong, Li, Tianliang, Saeed, Madiha, Xu, Zhiai, Zhong, Feisheng, Song, Rundi, Huai, Manxiu, Zheng, Mingyue, Xie, Cen, Xu, Leiming, Yu, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887571/ https://www.ncbi.nlm.nih.gov/pubmed/33643795 http://dx.doi.org/10.1002/advs.202002746 |
Ejemplares similares
-
Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer
por: Hu, Xianli, et al.
Publicado: (2020) -
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
por: Ye, Jiayi, et al.
Publicado: (2022) -
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
por: Li, Fenglin, et al.
Publicado: (2022) -
CD146‐Targeted Multimodal Image‐Guided Photoimmunotherapy of Melanoma
por: Wei, Weijun, et al.
Publicado: (2019) -
Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer
por: Zhu, Yun, et al.
Publicado: (2022)